Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin
(GVP, Chief Accounting Officer) |
S | Common Stock | D | 2286 | $90.00 - $90.00 | $205,740 |
| 2024-03-18 | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis
(Director) |
M | Common Stock | A | 10000 | $79.70 - $79.70 | $797,000 |
| 2024-03-18 | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis
(Director) |
F | Common Stock | D | 9510 | $83.81 - $83.81 | $797,033 |
| 2024-03-18 | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin
(GVP, Chief Accounting Officer) |
F | Common Stock | D | 372 | $83.87 - $83.87 | $31,199 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin
(GVP, Chief Accounting Officer) |
A | Common Stock | A | 4720 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
F | Common Stock | D | 21699 | $83.87 - $83.87 | $1,819,895 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
A | Common Stock | A | 10260 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg
(EVP, Chief Technical Officer) |
F | Common Stock | D | 20424 | $83.87 - $83.87 | $1,712,960 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg
(EVP, Chief Technical Officer) |
A | Common Stock | A | 10550 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
F | Common Stock | D | 20789 | $83.87 - $83.87 | $1,743,573 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
A | Common Stock | A | 11400 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J
(President, Worldwide R&D) |
F | Common Stock | D | 33485 | $83.87 - $83.87 | $2,808,386 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J
(President, Worldwide R&D) |
A | Common Stock | A | 18240 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Hardy Alexander
(Chief Executive Officer) |
A | Common Stock | A | 32780 | $0.00 - $0.00 | $0 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
F | Common Stock | D | 85209 | $83.87 - $83.87 | $7,146,478 |
| 2024-03-15 | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert
(EVP, Chief Commercial Officer) |
F | Common Stock | D | 22580 | $83.87 - $83.87 | $1,893,784 |
| 2024-03-05 | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J
(President, Worldwide R&D) |
S | Common Stock | D | 35341 | $85.18 - $85.18 | $3,010,395 |
| 2024-03-05 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
S | Common Stock | D | 2000 | $85.51 - $86.71 | $172,223 |
| 2024-03-05 | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert
(EVP, Chief Commercial Officer) |
S | Common Stock | D | 4000 | $87.07 - $87.07 | $348,280 |
| 2024-02-27 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
A | Common Stock | A | 36187 | $0.00 - $0.00 | $0 |
| 2024-02-27 | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg
(EVP, Chief Technical Officer) |
A | Common Stock | A | 36187 | $0.00 - $0.00 | $0 |
| 2024-02-27 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
S | Common Stock | D | 1000 | $90.35 - $90.35 | $90,350 |
| 2024-02-27 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
A | Common Stock | A | 143601 | $0.00 - $0.00 | $0 |
| 2023-02-06 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
G | Common Stock | D | 5600 | $0.00 - $0.00 | $0 |
| 2023-04-28 | BIOMARIN PHARMACEUTICAL INC | Mueller Brian
(EVP, Chief Financial Officer) |
A | Common Stock | A | 318 | $66.88 - $66.88 | $21,267 |
| 2024-01-08 | BIOMARIN PHARMACEUTICAL INC | MEIER RICHARD A
(Director) |
G | Common Stock | D | 3000 | $0.00 - $0.00 | $0 |
| 2024-01-09 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
S | Common Stock | D | 20000 | $96.38 - $98.19 | $1,945,700 |
| 2024-01-09 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
M | Common Stock | A | 20000 | $63.10 - $63.10 | $1,262,000 |
| 2024-01-08 | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JAC...
(Director) |
L | Common Stock | A | 50 | $99.05 - $99.05 | $4,952 |
| 2023-12-27 | BIOMARIN PHARMACEUTICAL INC | Countouriotis Athena
(Director) |
A | Common Stock | A | 2180 | $0.00 - $0.00 | $0 |
| 2023-12-13 | BIOMARIN PHARMACEUTICAL INC | Davis George Eric
(EVP, Chief Legal Officer) |
S | Common Stock | D | 13764 | $95.30 - $95.30 | $1,311,709 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |